1.
Cancer Research and Clinic
;
(6): 73-77, 2023.
Artigo
em Chinês
| WPRIM
| ID: wpr-996189
RESUMO
Breast cancer is the most common malignant tumor in women. It is particularly important to seek targeted therapy other than surgery, chemoradiotherapy, endocrine therapy. With the continuous exploration of tumor immunotherapy, more and more therapeutic targets have been discovered. This paper reviews therapeutic targets of chimeric antigen receptor T-cell (CAR-T) and the application in breast cancer.